Fragile Chromosomal Sites

Introduction to Fragile Chromosomal Sites

Fragile chromosomal sites are specific regions on chromosomes that are susceptible to gaps or breaks when cells are cultured under certain conditions. These sites are characterized by their tendency to form gaps, constrictions, or breaks on metaphase chromosomes. They are considered to be inherent structural features of chromosomes and can be observed in all individuals, although their expression may vary.

Fragile sites were first described in the 1970s and have since been the subject of extensive research due to their potential role in genomic instability, chromosome breakage syndromes, and cancer development. Understanding fragile sites is crucial for medical professionals, as they can contribute to various genetic disorders and may play a role in the initiation and progression of certain cancers.

Types of Fragile Sites

Fragile sites are classified into two main categories based on their frequency in the population and the conditions required for their expression:

  1. Common Fragile Sites (CFSs):
    • Present in all individuals
    • Comprise the majority of fragile sites (>80)
    • Induced by replication stress or DNA damage
    • Examples: FRA3B, FRA16D, FRA7G
  2. Rare Fragile Sites (RFSs):
    • Present in less than 5% of the population
    • Often associated with specific genetic disorders
    • Subdivided into folate-sensitive and non-folate-sensitive sites
    • Examples: FRAXA (Fragile X syndrome), FRA11B (Jacobsen syndrome)

Both types of fragile sites are further characterized by their molecular composition, with some containing expanded repetitive sequences (e.g., CGG repeats in FRAXA) and others associated with large genes or specific sequence motifs.

Clinical Significance

The clinical significance of fragile chromosomal sites extends to various aspects of human health and disease:

  1. Genetic Disorders: Rare fragile sites are associated with specific genetic syndromes. For example:
    • FRAXA: Fragile X syndrome (intellectual disability, autism spectrum disorders)
    • FRAXE: Mild to moderate intellectual disability
    • FRA11B: Jacobsen syndrome (developmental delay, intellectual disability, thrombocytopenia)
  2. Cancer Development: Common fragile sites are often located within or near important tumor suppressor genes and oncogenes. Their instability can lead to:
    • Deletions or inactivation of tumor suppressor genes
    • Amplification of oncogenes
    • Formation of fusion genes through chromosomal translocations
  3. Chromosomal Breakage Syndromes: Some genetic conditions, such as Fanconi anemia and ataxia-telangiectasia, show increased chromosomal breakage at fragile sites.
  4. Evolutionary Significance: Fragile sites may play a role in genome evolution and speciation by facilitating chromosomal rearrangements.

Understanding the clinical implications of fragile sites is essential for genetic counseling, cancer risk assessment, and the development of targeted therapies for genetic disorders and cancers associated with fragile site instability.

Diagnosis and Detection

Detecting and diagnosing fragile chromosomal sites involves various cytogenetic and molecular techniques:

  1. Cytogenetic Analysis:
    • Standard karyotyping with specific culture conditions (e.g., folate-deficient media for folate-sensitive sites)
    • Fluorescence in situ hybridization (FISH) for specific fragile sites
  2. Molecular Testing:
    • PCR-based assays for detecting expanded repeat sequences (e.g., CGG repeats in Fragile X syndrome)
    • Southern blot analysis for large expansions
    • Next-generation sequencing for comprehensive analysis of fragile site regions
  3. Genomic Microarrays:
    • Array comparative genomic hybridization (aCGH) for detecting copy number variations associated with fragile sites
  4. Functional Assays:
    • Replication timing analysis to assess delayed replication at fragile sites
    • Chromosome breakage studies for conditions like Fanconi anemia

Accurate diagnosis of fragile site-related disorders requires a combination of clinical evaluation, family history assessment, and appropriate laboratory testing. Medical professionals should be familiar with the indications for testing and the interpretation of results to provide proper genetic counseling and management.



Fragile Chromosomal Sites
  1. What are fragile sites on chromosomes?
    Specific chromosomal regions that tend to form gaps, constrictions, or breaks when cells are cultured under certain conditions
  2. How are fragile sites typically classified?
    Common fragile sites and rare fragile sites
  3. What is the most well-known fragile site associated with a genetic disorder?
    FRAXA (Fragile X syndrome site)
  4. On which chromosome is the FRAXA fragile site located?
    The X chromosome
  5. What is the underlying genetic cause of the fragile X syndrome fragile site?
    CGG trinucleotide repeat expansion in the FMR1 gene
  6. How many CGG repeats are typically found in the FMR1 gene of unaffected individuals?
    5-44 repeats
  7. What range of CGG repeats in the FMR1 gene is considered a "premutation"?
    55-200 repeats
  8. How many CGG repeats in the FMR1 gene typically result in the full fragile X syndrome?
    More than 200 repeats
  9. What happens to the FMR1 gene when the number of CGG repeats exceeds 200?
    It becomes methylated and transcriptionally silenced
  10. What protein is absent or reduced in fragile X syndrome?
    FMRP (Fragile X Mental Retardation Protein)
  11. What is the name of the fragile site associated with Jacobsen syndrome?
    FRA11B
  12. On which chromosome is the FRA11B fragile site located?
    Chromosome 11
  13. What type of repeat expansion is associated with the FRA11B fragile site?
    CGG trinucleotide repeat expansion
  14. What is the most common chromosomal fragile site in the human genome?
    FRA3B on chromosome 3
  15. Which gene is located at the FRA3B fragile site?
    FHIT (Fragile Histidine Triad) gene
  16. What type of fragile site is FRA3B?
    Common fragile site
  17. How many common fragile sites have been identified in the human genome?
    More than 80
  18. What conditions can induce the expression of common fragile sites in cell culture?
    Folate deficiency or addition of aphidicolin (DNA polymerase inhibitor)
  19. What is the characteristic appearance of a fragile site under a microscope?
    A non-staining gap or constriction in the chromosome
  20. Which rare fragile site is associated with folate-sensitive mental retardation?
    FRAXE
  21. On which chromosome is the FRAXE fragile site located?
    The X chromosome
  22. What type of repeat expansion is associated with the FRAXE fragile site?
    CCG trinucleotide repeat expansion
  23. Which gene is affected by the FRAXE fragile site?
    FMR2 gene
  24. What is the name of the fragile site associated with Wolf-Hirschhorn syndrome?
    FRA16B
  25. On which chromosome is the FRA16B fragile site located?
    Chromosome 16
  26. What type of repeat is expanded in the FRA16B fragile site?
    AT-rich minisatellite repeats
  27. What is the name of the fragile site associated with aphidicolin-induced common fragile site on chromosome 7?
    FRA7G
  28. Which gene is located at the FRA7G fragile site?
    MDFIC (MyoD Family Inhibitor Domain Containing) gene
  29. What is the proposed role of common fragile sites in cancer development?
    They may act as preferential sites for DNA breakage, leading to chromosomal rearrangements and gene alterations in cancer cells
  30. What technique is commonly used to visualize fragile sites on chromosomes?
    Fluorescence in situ hybridization (FISH)
  31. What is the name of the fragile site associated with Seckel syndrome?
    FRA18A
  32. On which chromosome is the FRA18A fragile site located?
    Chromosome 18
  33. What type of fragile site is FRA18A?
    Rare, folate-sensitive fragile site
  34. What is the proposed mechanism for the formation of gaps or breaks at fragile sites?
    Delayed replication and incomplete chromosome condensation
  35. Which protein complex is important for the stability of common fragile sites during replication stress?
    ATR-CHK1 pathway proteins


Further Reading
Powered by Blogger.